Insulin Resistance Syndrome: Difference between revisions

Latest revision as of 03:24, 17 November 2007

Redirect to:

Revision as of 18:31, 3 November 2007 (view source) imported>Subpagination Bot m (Add {{subpages}} and remove any categories (details)) ← Older edit		Latest revision as of 03:24, 17 November 2007 (view source) imported>Pierre-Alain Gouanvic (Redirecting to Metabolic syndrome)
(One intermediate revision by the same user not shown)
Line 1:		Line 1:
	~~{{subpages}}~~		#REDIRECT [[Metabolic syndrome]]

	~~The '''insulin resistance syndrome''' is a "constellation of findings, including [[central obesity]], [[glucose intolerance]],~~ [[dyslipidemia]], and [[hypertension]], that promotes the development of [[type 2 diabetes mellitus]], [[cardiovascular disease]], [[Cancer\|cancer]], [[polycystic ovary syndrome\|polysystic ovary syndrome]] (PCOS), and nonalcoholic fatty liver disease".(reference for quote: Sudha B. Biddinger & C. Ronald Kahn : FROM MICE TO MEN: Insights into the Insulin Resistance Syndromes.Annual Review of Physiology Vol. 68: 123-158 (Volume publication date January 2006) (doi:10.1146/annurev.physiol.68.040104.124723)). As [[Obesity\|obesity]] has reached epidemic proportions in many countries of the developed world, a pattern of these findings has become recognized. Also called the metabolic syndrome, the dysmetabolic syndrome~~, or syndrome, this association of [[Physiology\|physiologic findings]] is the focus of current research in [[medicine~~]].